"How Venture Capital can Add Value in the Low Margin FMCG Market"

Session Speaker " Money, Money, Money! Raising Capital in the Post-GFC Market"

Session Speaker " Capital Markets: A Critical Factor in an Effective Innovation Ecosystem"

Dr Andrew Kelly is one of Australia-New Zealand’s most experienced biotech investment managers.  He is Executive Director and co-founder of BioPacificVentures, the $100 million venture capital fund specialising in health and wellness.  The fund has completed 11 investments to date and is part of the Direct Capital group which has completed more than 60 investments over 15 years.

The first 20 years of Andrew’s career were in science, including General Manager at AgResearch, Director of two research institutes in Victoria, and both MSc and PhD degrees.